No abstract available
MeSH terms
-
Drug Approval*
-
Fluorobenzenes / adverse effects*
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
-
Muscular Diseases / chemically induced
-
Pyrimidines / adverse effects*
-
Renal Insufficiency / chemically induced
-
Rhabdomyolysis / chemically induced
-
Rosuvastatin Calcium
-
Sulfonamides / adverse effects*
-
United States
-
United States Food and Drug Administration
Substances
-
Fluorobenzenes
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Pyrimidines
-
Sulfonamides
-
Rosuvastatin Calcium